(Q39668615)

13 September 2017

Analysis of Ki-67 antigen expression, DNA proliferative fraction, and survival in resected cancer of the pancreas (English)

1 reference

13 September 2017

0 references

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

28 March 2024

author name string

Katie J. Stanton

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14599612

28 March 2024

Richard A. Sidner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14599612

28 March 2024

Greg A. Miller

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14599612

28 March 2024

Oscar W. Cummings

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14599612

28 March 2024

C. Max Schmidt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14599612

28 March 2024

Thomas J. Howard

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14599612

28 March 2024

Eric A. Wiebke

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14599612

28 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S0002961003003258?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

https://api.elsevier.com/content/article/PII:S0002961003003258?httpAccept=text/plain

28 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

The American Journal of Surgery

28 March 2024

published in

1 reference

13 September 2017

186

1 reference

13 September 2017

486-492

1 reference

13 September 2017

5

1 reference

13 September 2017

Cancer statistics, 2003.

1

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

Role of surgical treatment in pancreatic carcinoma

28 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality

28 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

Survival in 1001 patients with carcinoma of the pancreas

28 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

Cancer of the pancreas. 50 years of surgery

28 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

Improved hospital morbidity, mortality, and survival after the Whipple procedure

28 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

Decreased morbidity and mortality after pancreatoduodenectomy

28 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

An analysis of the reduced morbidity and mortality rates after pancreaticoduodenectomy.

28 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

Relevant factors in the prognosis of ductal pancreatic carcinoma

28 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer

28 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

Pancreas cancer — duct cell adenocarcinoma: Survival in relation to site, size, stage and type of therapy

28 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

Factors influencing survival after resection for ductal adenocarcinoma of the pancreas

28 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance

28 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma

28 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma

28 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

Pancreatic Cancer Cell DNA Content Correlates With Long-term Survival After Pancreatoduodenectomy

28 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

DNA Ploidy, S-Phase Fraction, and G2 Fraction as Prognostic Determinants in Human Pancreatic Cancer

28 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

Evaluation of DNA Nuclear Pattern as a Prognostic Determinant in Resected Pancreatic Ductal Adenocarcinoma

28 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

The role of flow cytometric DNA analysis in determining prognosis of resectable ductal adenocarcinoma of the pancreas

28 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

The Ki-67 protein: from the known and the unknown

28 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry

28 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

A Detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis

28 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

New antiserum against Ki-67 antigen suitable for double immunostaining of paraffin wax sections

28 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

MIB-1 in endometrial carcinoma: prognostic significance with 5-year follow-up

28 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

Prognostic indicators for survival after resection of pancreatic adenocarcinoma.

28 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

Ki67 protein: the immaculate deception?

28 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies

28 March 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

The proliferation-associated Ki-67 protein: definition in molecular terms

28 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer

28 March 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas

28 March 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (PanIN): additional evidence for a recently proposed model of progression

28 March 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.AMJSURG.2003.07.002

28 March 2024

Identifiers

1 reference

13 September 2017

1 reference